Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
---|
05/10/2002 | WO2002036774A2 Derivatives of the human macrophage-migration inhibition factor (mif) and use thereof in pharmaceutical preparations in screening methods or the identification of analogues, agonists and antagonists |
05/10/2002 | WO2002036771A2 Imaging, diagnosis and treatment of disease |
05/10/2002 | WO2002036769A2 Nucleic acids encoding cd40/cd40l chimeric polypeptides, methods for their production and uses thereof |
05/10/2002 | WO2002036767A2 Therapeutic oligonucleotides of reduced toxicity |
05/10/2002 | WO2002036765A1 Novel protein and dna thereof |
05/10/2002 | WO2002036763A1 Novel gene overexpressed in heart and skeletal muscle and use tehreof |
05/10/2002 | WO2002036761A2 Compositions and methods for the diagnosis of cancer |
05/10/2002 | WO2002036733A2 Cd36 as a heat shock protein receptor and uses thereof |
05/10/2002 | WO2002036634A2 Gene regulation therapy involving ferritin |
05/10/2002 | WO2002036613A2 Regulation of human patched-like protein |
05/10/2002 | WO2002036170A2 Vector system for transducing the positive neurons |
05/10/2002 | WO2002036167A1 Formulations comprising dextrin polymers in combination with sugars for the delivery of nucleic acids |
05/10/2002 | WO2002036150A1 Gene-digesting gene and enzyme having vaccine-like effect |
05/10/2002 | WO2002036149A2 Methods for obtaining inhibitors of t-cell membrane protein (tirc7) ligand binding and uses thereof |
05/10/2002 | WO2002036131A1 In vivo stimulation of angiogenic activity |
05/10/2002 | WO2002036108A2 Use of 20-hete synthesizing enzyme inhibitors as therapy for cerebral vascular diseases |
05/10/2002 | WO2002035981A2 Methods and compositions for the treatment of human immunodeficiency virus infection |
05/10/2002 | WO2002022798A3 Modulation of homologous recombination with single stranded dna binding proteins |
05/10/2002 | WO2001096525A3 A novel polypeptide, a pogo conversion unit 18 and the polynucleotide encoding the polypeptide |
05/10/2002 | WO2001089564A3 Methods for diagnosing and treating hemostatic disorders by modulating p-selectin activity |
05/10/2002 | WO2001088116A3 Method of modulating activation of lymphocytes via modulation of pituitary tumor transforming gene, related screeining methods |
05/10/2002 | WO2001085993A3 Method for detecting growth hormone variations in humans, the variations and their uses |
05/10/2002 | WO2001083750A3 Dendritic cell co-stimulator molecules |
05/10/2002 | WO2001083711A3 Clearance of ras-mediated neoplastic cells from mixed cellular compositions using reovirus |
05/10/2002 | WO2001079469A3 Cloning of corynebacteriaceae histidine ammonia lyase and therapeutic uses |
05/10/2002 | WO2001070808A3 Angiogenesis - associated proteins, and nucleic acids encoding the same |
05/10/2002 | WO2001068697A3 Methods and compositions for immunoregulation |
05/10/2002 | WO2001068135A3 Compositions and methods for affecting osteogenesis |
05/10/2002 | WO2001064908A3 14790, a protein kinase and uses therefor |
05/10/2002 | WO2001055323A3 Nucleic acids, proteins, and antibodies |
05/10/2002 | WO2001048190A3 Therapeutic uses of lna-modified oligonucleotides |
05/10/2002 | WO2001047963A3 Inhibitors of complement activation, their preparation and use |
05/10/2002 | WO2001047955A3 Improvements in or relating to immune responses to hiv |
05/10/2002 | WO2001046455A3 Survivin promotion of angiogenesis |
05/10/2002 | WO2001042481A3 Canine adenovirus vectors for the transfer of genes into target cells |
05/10/2002 | WO2001042472A3 DNA ENCODING A NOVEL PROST-Ets POLYPEPTIDE |
05/10/2002 | WO2001042296A3 Clasp-5 transmembrane protein |
05/10/2002 | WO2001036638A3 Polypeptides and nucleic acids encoding same |
05/10/2002 | WO2001036618A3 Transgenic mammals into which a period 1 promoter that confers rhythmical expression has been introduced |
05/10/2002 | WO2001036487A3 Antigen-binding fragments specific for dendritic cells, compositions and methods of use thereof antigens recognized thereby and cells obtained thereby |
05/10/2002 | WO2001036486A3 Scfv antibodies against disease associated molecules |
05/10/2002 | WO2001036446A3 Use of g-protein coupled receptors (gpcrs) and modified gpcrs for the treatment of diseases |
05/10/2002 | WO2001036432A3 18 human secreted proteins |
05/10/2002 | WO2001032709A3 Polypeptides with non-natural primary signalling motifs |
05/10/2002 | WO2001028580A3 Modulation of angiogenesis |
05/10/2002 | WO2001026643A9 Inhibition of tumorigenic properties of melanoma cells |
05/10/2002 | WO2001026629A3 Neutral-cationic lipid for nucleic acid and drug delivery |
05/10/2002 | WO2001025271A3 Fibroblast growth factor-5 (fgf-5) is a tumor associated t-cell antigen |
05/10/2002 | WO2001021203A9 Use of an outer membrane protein a of an enterobacterium associated with a rsv immunogenic peptide for preparing vaccines for intranasal administration |
05/10/2002 | WO2000073507A3 Identification of a novel retrovirus associated with primary biliary cirrhosis and autoimmune disorders |
05/10/2002 | WO2000067761A8 Compositions and methods for identifying antigens which elicit an immune response |
05/10/2002 | WO2000058339A3 50 human secreted proteins |
05/10/2002 | WO2000042208A8 Adenovirus vectors, packaging cell lines, compositions, and methods for preparation and use |
05/10/2002 | CA2427802A1 Methods and compositions for the diagnosis of cancer susceptibilites and defective dna repair mechanisms and treatment thereof |
05/10/2002 | CA2427629A1 Gene regulation therapy involving ferritin |
05/10/2002 | CA2427557A1 Use of 20-hete synthesizing enzyme inhibitors as therapy for cerebral vascular diseases |
05/10/2002 | CA2427163A1 Influenza virus vector for infection of dendritic cells |
05/10/2002 | CA2426658A1 Methods of diagnosing, preventing and treating neurological disorders and neuronal injuries |
05/10/2002 | CA2426047A1 Therapeutic oligonucleotides of reduced toxicity |
05/10/2002 | CA2425583A1 Methods for obtaining inhibitors of tirc7 ligand binding and uses thereof |
05/10/2002 | CA2424932A1 Cd36 as a heat shock protein receptor and uses thereof |
05/09/2002 | US20020056148 Generating vertebrate geneticaly engineered stem cells; administer transfection mixture into gonad, allow vector insertion into genome, monitor germ cells for expression of marker |
05/09/2002 | US20020056144 Transgenic animal models for cardiac hypertrophy and methods of use thereof (screening) |
05/09/2002 | US20020055627 Nucleotide sequences coding cancer antigens for use in the detection treatment and prevention of cancer of colon and/or rectum |
05/09/2002 | US20020055618 Methods and substances for preventing and treating autoimmune disease |
05/09/2002 | US20020055482 Molecular constructs with a carcinoembryonic antigen (cea) transcriptional regulatory sequence |
05/09/2002 | US20020055480 SOX-9 gene and protein and use in the regeneration of bone or cartilage |
05/09/2002 | US20020055479 Treating type 2 diabetes, metabolic disorders, obesity and cancer. |
05/09/2002 | US20020055478 Monitoring 103P3E8 gene products in a biological sample from a patient who has or who is suspected of having cancer and comparing the gene expression products with that of a normal sample |
05/09/2002 | US20020055477 Immunomodulatory formulations and methods for use thereof |
05/09/2002 | US20020055476 RAMPs are small proteins that transport calcitonin-receptor-like proteins to the plasma membrane; drug screening |
05/09/2002 | US20020055475 Cytidylyl(3'-->5')guanosine ammonium salt (CpG); reducing the immunostimulatory effect for antisense applications |
05/09/2002 | US20020055467 Truncated neublastin, of the glial cell-derived nerve growth factor (GDNF) subfamily; when dimerized, binds to a RET (a receptor tyrosine kinase) polypeptide |
05/09/2002 | US20020055174 Complex for transferring an anionic substance of interest into a cell |
05/09/2002 | US20020055173 Plasmids for use in expressing heterologous proteins on surface viral particle and for use in gene therapy |
05/09/2002 | US20020055160 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
05/09/2002 | US20020055158 Human tissue inhibitor of metalloproteinase-4 |
05/09/2002 | US20020055147 Nucleotide sequences coding cytokine; for use in the treatment of immunological defects, allergies, asthma and arthritis |
05/09/2002 | US20020055142 Major intrinsic protein (MIP)-like polynucleotides, polypeptides, and antibodies |
05/09/2002 | US20020055131 Use of thioredoxin as, inter alia, a cell growth stimulator, as well as a screen for agents that are useful in reducing or eliminating thioredoxin-associated apoptosis inhibition and thioredoxin stimulated cell growth |
05/09/2002 | US20020055130 Method and product for regulating apoptosis |
05/09/2002 | US20020054902 Liposomes containing therapeutic genes are conjugated to targeting agents to provide transport of encapsulated gene across blood-retainal barrier and plasma membrane of ocular cell, where this gene expresses encoded therapeutical agent |
05/09/2002 | US20020054865 An anaerobic bacterium belonging to the genus Bifidobacterium capable of expressing a gene coding for a protein having an antitumor activity in only cancer cells under anaerobic conditions; reduced toxicity |
05/09/2002 | US20020054864 Generating a DNA fragment which expresses an antigenic protein or fragment; distributing on the particle surface to form particlulate polynucleotide, deliverying it to the cytoplasm of target cell to express antigenic protein |
05/08/2002 | EP1203827A2 Polymorphisms in the human KDR gene |
05/08/2002 | EP1203819A2 Anti-inflammatory vectors |
05/08/2002 | EP1203817A2 Compounds and methods for immunotherapy and diagnosis of tuberculosis |
05/08/2002 | EP1203813A2 Attenuated pestiviruses |
05/08/2002 | EP1203812A2 Attenuated pestiviruses |
05/08/2002 | EP1203092A1 Antisense modulation of map kinase kinase 6 expression |
05/08/2002 | EP1203088A2 Conditionally controlled, attenuated hiv vaccine |
05/08/2002 | EP1203084A1 Microencapsulated nitric oxide synthase source |
05/08/2002 | EP1203081A2 Human intracellular signaling molecules |
05/08/2002 | EP1203024A1 Human tumor necrosis factor receptors tr13 and tr14 |
05/08/2002 | EP1203020A1 Modulation of human sodium channels in dorsal root ganglia |
05/08/2002 | EP1203018A1 26 human prostate and prostate cancer associated proteins |
05/08/2002 | EP1203010A1 Antisense modulation of fadd expression |
05/08/2002 | EP1203009A1 Antisense modulation of jun n-terminal kinase kinase-1 expression |
05/08/2002 | EP1203008A1 Nucleic acid ligands to cd40ligand |
05/08/2002 | EP1203005A2 25 human secreted proteins |